Robbins LLP says Hims faces securities class action over privacy, billing claims
Robbins LLP says a securities class action has been filed against Hims & Hers Health over alleged sharing of protected health information and deceptive billing practices.
Robbins LLP said investors in Hims & Hers Health may be eligible to join a securities class action tied to allegations over health data sharing and billing practices.
Robbins LLP said on Sept. 3 that a securities class action has been filed against Hims & Hers Health, Inc. over allegations that the telehealth company shared customers’ protected health information with advertising platforms and made deceptive statements about its business practices.
The notice says the case covers investors who bought or otherwise acquired Hims shares between Aug. 4, 2025, and July 29, 2026. It says the lead-plaintiff deadline is Nov. 2, 2026.
The notice ties the investor claims to a separate enforcement action by the Federal Trade Commission. According to the notice, the FTC said on July 29, 2026, that it had filed a lawsuit against Hims alleging the company shared sensitive health information with third-party advertising platforms and misled users about billing and cancellation practices.
The complaint alleges Hims did not clearly disclose that it charges consumers for prescriptions almost immediately after intake forms. It also says the FTC complaint challenged a promise that the platform was “100% online, private, and secure.”
Hims is described in the notice as a health and wellness platform that connects consumers to licensed healthcare professionals. The notice says the alleged conduct exposed the company to regulatory scrutiny, fees and penalties, and that earlier positive statements about the company’s business, operations and prospects were materially misleading or lacked a reasonable basis.
Robbins LLP said the FTC complaint alleges data sharing with advertising companies and platforms including Meta Platforms, Inc. and Snap Inc. The notice also says Hims shares fell $4.32, or 14.73%, to $25.00 on July 29, 2026, after the FTC announcement.
The notice says investors who suffered losses during the class period may be eligible to participate, and that a lead plaintiff is a court-appointed investor who represents the class. It says investors do not need to serve as lead plaintiff to seek any potential recovery.
Brian J. Robbins, quoted in the notice, said companies have an obligation to provide complete and accurate information so markets can function fairly and efficiently.
The notice contains an internal inconsistency in one eligibility section, which refers to XTI Aerospace common stock instead of Hims & Hers Health. The rest of the notice is about Hims.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Comments ()